• 492 Citations
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

I have an interest in the development of clinical trials, as well as studying novel biomarkers that may be used as prognostic and predictive tools in the management of melanoma and other advanced skin cancers, as well as cancer of unknown primary.

Training Experience

2011Residency, Case Western Reserve University Hospital
2014Fellowship, New York University Medical Center

Education/Academic qualification

MD, Michigan State University

… → 2008

MS, Michigan State University

… → 2003

Research interests

  • Cancer of Unknown Primary
  • Cancer of unknown primary
  • Cancer: Skin
  • Clinical Research
  • Drug Discovery
  • Melanoma
  • Skin Cancer
  • Translational Research

Fingerprint Dive into the research topics where Sunandana Chandra is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Precision Medicine Medicine & Life Sciences
CTLA-4 Antigen Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2013 2022

Research Output 2012 2019

Adverse Events Associated with Immune Checkpoint Inhibitors - Reply

Johnson, D. B., Chandra, S. & Sosman, J. A., Mar 26 2019, In : JAMA - Journal of the American Medical Association. 321, 12, p. 1219-1220 2 p.

Research output: Contribution to journalLetter

Clinical characterization of colitis arising from anti-PD-1 based therapy

Wang, D. Y., Mooradian, M. J., Kim, D. W., Shah, N. J., Fenton, S. E., Conry, R. M., Mehta, R., Silk, A. W., Zhou, A., Compton, M. L., Al-Rohil, R. N., Lee, S., Voorhees, A. L., Ha, L., McKee, S., Norrell, J. T., Mehnert, J., Puzanov, I., Sosman, J. A., Chandra, S. & 5 others, Gibney, G. T., Rapisuwon, S., Eroglu, Z., Sullivan, R. & Johnson, D. B., Jan 2 2019, In : OncoImmunology. 8, 1, e1524695.

Research output: Contribution to journalArticle


Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

Eroglu, Z., Holmen, S. L., Chen, Q., Khushalani, N. I., Amaravadi, R., Thomas, R., Ahmed, K. A., Tawbi, H., Chandra, S., Markowitz, J., Smalley, I., Liu, J. K. C., Chen, Y. A., Najjar, Y. G., Karreth, F. A., Abate-Daga, D., Glitza, I. C., Sosman, J. A., Sondak, V. K., Bosenberg, M. & 7 others, Herlyn, M., Atkins, M. B., Kluger, H., Margolin, K., Forsyth, P. A., Davies, M. A. & Smalley, K. S. M., May 1 2019, In : Pigment Cell and Melanoma Research. 32, 3, p. 458-469 12 p.

Research output: Contribution to journalArticle

Open Access
Central Nervous System
Neoplasm Metastasis
6 Citations (Scopus)
Clinical Trials
CD274 Antigen
33 Citations (Scopus)
Non-Small Cell Lung Carcinoma
Clinical Trials
CTLA-4 Antigen